filmov
tv
AstraZeneca CEO Pascal Soriot breaks down data on new 'transformative' breast cancer drug
![preview_player](https://i.ytimg.com/vi/QEL7GXhx6u4/maxresdefault.jpg)
Показать описание
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBCTV
AstraZeneca CEO Pascal Soriot breaks down data on new 'transformative' breast cancer drug
Leaders with Lacqua: Astrazeneca CEO Pascal Soriot
Recording of AstraZeneca CEO Pascal Soriot ‘Millions of [Immunocompromised] People Can’t Be Vaxxed&a...
AstraZeneca CEO on Cancer Treatment, Covid in China
Breakingviews TV: AstraZeneca's big and bold deal
AstraZeneca CEO Pascal Soriot on progress on pancreatic cancer
AstraZeneca CEO on Vaccine Unit, Covid Endemic Stage
AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer
H1 2021 financial results: Pascal Soriot, CEO
AstraZeneca 'within striking distance' of curing some cancers, CEO says | CNBC Conversatio...
AstraZeneca CEO Sees Covid Vaccine on Track for Year End
AstraZeneca CEO: “Covid Is Here To Stay”
We expect slight decline in China due to price pressures, AstraZeneca CEO says
AstraZeneca CEO awaits diagnosis on Covid-19 trial participant who developed neurological condition
Brexit preparations have cost £40 million to £50 million: AstraZeneca CEO | Street Signs Europe
AstraZeneca CEO on Covid-19 vaccine efforts, BARDA funding and more
AstraZeneca CEO receives knighthood
Pascal Soriot, AstraZeneca: Real Innovation Requires Risk
Bloomberg Turnaround: How to Take Advantage of a $117 Billion Takeover Bid
AstraZeneca's CEO says its vaccine should work against severe infections while studies suggest ...
Pascal Soriot | Trust Experts
Not clear yet if we need a third booster for the vaccine: AstraZeneca CEO
AstraZeneca's Business Strategy | Earnings Call Webinar
AstraZeneca CEO on revenue beat
Комментарии